Last reviewed · How we verify
Anti-hypertensive drug treatment
Anti-hypertensive drug treatment is a Angiotensin II receptor blocker Small molecule drug developed by Universidade Gama Filho. It is currently in Phase 2 development for Hypertension. Also known as: Thiazide Diuretics, Aldosterone receptor antagonist, Beta-blockers, ACE inhibitors.
Blocks the action of angiotensin II at its receptor
Blocks the action of angiotensin II at its receptor Used for Hypertension.
At a glance
| Generic name | Anti-hypertensive drug treatment |
|---|---|
| Also known as | Thiazide Diuretics, Aldosterone receptor antagonist, Beta-blockers, ACE inhibitors, Angiotensin receptor blockers |
| Sponsor | Universidade Gama Filho |
| Drug class | Angiotensin II receptor blocker |
| Target | AT1 receptor |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 2 |
Mechanism of action
This is achieved through the use of angiotensin II receptor blockers (ARBs), which are a class of medications that are used to treat high blood pressure.
Approved indications
- Hypertension
Common side effects
- Dizziness
- Headache
- Fatigue
Key clinical trials
- CENtral Blood Pressure Targeting: A Pragmatic RAndomized Pilot triaL in Advanced Chronic Kidney Disease (NA)
- BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT (NA)
- The GUARDIAN Pilot Trial (NA)
- Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity (PHASE3)
- Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control (NA)
- Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance (PHASE4)
- SPYRAL GEMINI Pilot Study (NA)
- Effects of Antihypertensive Drug Treatment on Brain Blood Flow, Cognition, and Regulation of Nervous System in Older Adults With Hypertension. (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Anti-hypertensive drug treatment CI brief — competitive landscape report
- Anti-hypertensive drug treatment updates RSS · CI watch RSS
- Universidade Gama Filho portfolio CI
Frequently asked questions about Anti-hypertensive drug treatment
What is Anti-hypertensive drug treatment?
How does Anti-hypertensive drug treatment work?
What is Anti-hypertensive drug treatment used for?
Who makes Anti-hypertensive drug treatment?
Is Anti-hypertensive drug treatment also known as anything else?
What drug class is Anti-hypertensive drug treatment in?
What development phase is Anti-hypertensive drug treatment in?
What are the side effects of Anti-hypertensive drug treatment?
What does Anti-hypertensive drug treatment target?
Related
- Drug class: All Angiotensin II receptor blocker drugs
- Target: All drugs targeting AT1 receptor
- Manufacturer: Universidade Gama Filho — full pipeline
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Hypertension
- Also known as: Thiazide Diuretics, Aldosterone receptor antagonist, Beta-blockers, ACE inhibitors, Angiotensin receptor blockers
- Compare: Anti-hypertensive drug treatment vs similar drugs
- Pricing: Anti-hypertensive drug treatment cost, discount & access